Simon Bury joins Selcia as business development director
This article was originally published in Scrip
Executive Summary
Simon Bury has joined the Discovery division of CRO Selcia as business development director to lead expansion plans in its drug discovery offering. Mr Bury most recently served as chief commercial officer for Cyprotex Discovery, where he was responsible for the company's global sales and marketing activities.